Changes in disease characteristics of primary biliary cholangitis: An observational retrospective study from 1982 to 2016

被引:8
作者
Takamura, Masaaki [1 ]
Matsuda, Yasunobu [2 ]
Kimura, Naruhiro [1 ]
Takatsuna, Masafumi [1 ]
Setsu, Toru [1 ]
Tsuchiya, Atsunori [1 ]
Osaki, Akihiko [3 ]
Waguri, Nobuo [3 ]
Yanagi, Masahiko [14 ]
Takahashi, Toru [14 ]
Sugitani, Soichi [15 ]
Kobayashi, Yuka [16 ]
Yoshikawa, Akira
Ishikawa, Toru [4 ]
Yoshida, Toshiaki [4 ]
Watanabe, Toshiaki [17 ]
Bannai, Hitoshi [18 ]
Kubota, Tomoyuki [5 ]
Funakoshi, Kazuhiro [19 ]
Wakabayashi, Hiroto [21 ]
Kurita, So [6 ]
Ogata, Norio [6 ]
Watanabe, Masashi [20 ]
Mita, Yuhsaku [7 ]
Mori, Shigeki [8 ]
Sugiyama, Motoya [9 ]
Miyajima, Toru [10 ]
Takahashi, Sumio [11 ]
Sato, Shuichi [12 ]
Ishizuka, Kisei [13 ]
Ohta, Hironobu [13 ]
Aoyagi, Yutaka [11 ]
Terai, Shuji [1 ]
机构
[1] Niigata Univ, Grad Sch Med & Dent Sci, Div Gastroenterol & Hepatol, Niigata, Japan
[2] Niigata Univ, Grad Sch Med & Dent Sci, Dept Med Technol, Niigata, Japan
[3] Niigata City Gen Hosp, Niigata, Japan
[4] Saiseikai Niigata Hosp, Niigata, Japan
[5] Niigata Rinko Hosp, Niigata, Japan
[6] Niigata Canc Ctr Hosp, Niigata, Japan
[7] Niigataminami Hosp, Niigata, Japan
[8] Niitsu Med Ctr Hosp, Niigata, Japan
[9] Sugiyama Internal Med Clin, Yamagata, Japan
[10] JA Niigata Kouseiren Toyosaka Hosp, Niigata, Japan
[11] JA Niigata Med Ctr, Niigata, Japan
[12] Kido Hosp, Niigata, Japan
[13] Niigata Shirone Gen Hosp, Niigata, Japan
[14] JA Niigata Kouseiren Ojiya Gen Hosp, Ojiya, Japan
[15] JA Niigata Kouseiren Murakami Gen Hosp, Murakami, Japan
[16] JA Niigata Kouseiren Nagaoka Chuo Gen Hosp, Nagaoka, Niigata, Japan
[17] Watanabe Clin, Toyohashi, Aichi, Japan
[18] Niigata Saiseikai Sanjo Hosp, Sanjo, Japan
[19] Niigata Prefectural Cent Hosp, Joetsu, Japan
[20] Niigata Prefectural Shibata Hosp, Niigata, Japan
[21] Takeda Gen Hosp, Aizu Wakamatsu, Fukushima, Japan
基金
日本学术振兴会;
关键词
age; asymptomatic; gender; outcome; primary biliary cholangitis; ursodeoxycholic acid; URSODEOXYCHOLIC ACID; BIOCHEMICAL RESPONSE; CLINICAL-FEATURES; CONTROLLED-TRIAL; CIRRHOSIS; BEZAFIBRATE; PROGNOSIS; PROGRESSION; PREDICTION; THERAPY;
D O I
10.1111/hepr.13586
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aim Disease characteristics of primary biliary cholangitis have changed recently. However, detailed studies on the subject have been limited. Therefore, we aimed to clarify disease characteristics of patients with recent primary biliary cholangitis using the cohort from Niigata University and 21 affiliated hospitals. Methods Overall, 508 patients were enrolled in this study from 1982 to 2016, divided into three cohorts according to their year of diagnosis: <= 1999, 2000-2009 and >= 2010. We compared differences in clinical characteristics, response to ursodeoxycholic acid and prognosis. Results The male-to-female ratio increased incrementally from 1:16.4 (<= 1999) to 1:3.8 (>= 2010) (P < 0.001). In women, the median age at diagnosis increased incrementally from 54.0 years (<= 1999) to 60.5 years (>= 2010) (P < 0.001) and serum albumin decreased gradually (P = 0.001), which might have affected the increase in the Fibrosis-4 Index and albumin-bilirubin score. The ursodeoxycholic acid response rate according to the Barcelona criteria increased incrementally from 26.7% (<= 1999) to 78.4% (>= 2010) (P < 0.010), and those according to other criteria (Paris-I, Rotterdam and Toronto) were approximately >= 80% in all cohorts. Ten-year survival rate in the <= 1999 and 2000-2009 cohorts were 98.6% and 95.6%, respectively. These earlier cohorts were also characterized by a higher rate of asymptomatic state and mild histology (83.5% [<= 1999] and 84.7% [2000-2009], and 93.6% [<= 1999] and 91.1% [2000-2009]). Conclusions Patients with primary biliary cholangitis were characterized by older age at diagnosis and an increase in male to female ratio as well as higher response rates of ursodeoxycholic acid and longer survival, resulting from the early recognition of primary biliary cholangitis.
引用
收藏
页码:166 / 175
页数:10
相关论文
共 34 条
  • [1] The UK-PBC Risk Scores: Derivation and Validation of a Scoring System for Long-Term Prediction of End-Stage Liver Disease in Primary Biliary Cholangitis
    Carbone, Marco
    Sharp, Stephen J.
    Flack, Steve
    Paximadas, Dimitrios
    Spiess, Kelly
    Adgey, Carolyn
    Griffiths, Laura
    Lim, Reyna
    Trembling, Paul
    Williamson, Kate
    Wareham, Nick J.
    Aldersley, Mark
    Bathgate, Andrew
    Burroughs, Andrew K.
    Heneghan, Michael A.
    Neuberger, James M.
    Thorburn, Douglas
    Hirschfield, Gideon M.
    Cordell, Heather J.
    Alexander, Graeme J.
    Jones, David E. J.
    Sandford, Richard N.
    Mells, George F.
    [J]. HEPATOLOGY, 2016, 63 (03) : 930 - 950
  • [2] Primary biliary cirrhosis autoimmune hepatitis overlap syndrome:: Clinical features and response to therapy
    Chazouillères, O
    Wendum, D
    Serfaty, L
    Montembault, S
    Rosmorduc, O
    Poupon, R
    [J]. HEPATOLOGY, 1998, 28 (02) : 296 - 301
  • [3] Effects of Age and Sex of Response to Ursodeoxycholic Arid and Transplant-free Survival in Patients With Primary Biliary Cholangitis
    Cheung, Angela C.
    Lammers, Willem J.
    Perez, Carla F. Murillo
    van Buuren, Henk R.
    Gulamhusein, Aliya
    Trivedi, Palak J.
    Lazaridis, Konstantinos N.
    Ponsioen, Cyriel Y.
    Floreani, Annarosa
    Hirschfield, Gideon M.
    Corpechot, Christophe
    Mayo, Marlyn J.
    Invernizzi, Pietro
    Battezzati, Pier Maria
    Pares, Albert
    Nevens, Frederik
    Thorburn, Douglas
    Mason, Andrew L.
    Carbone, Marco
    Kowdley, Kris V.
    Bruns, Tony
    Dalekos, George N.
    Gatselis, Nikolaos K.
    Verhelst, Xavier
    Lindor, Keith D.
    Lleo, Ana
    Poupon, Raoul
    Janssen, Harry L. A.
    Hansen, Bettina E.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (10) : 2076 - +
  • [4] A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis
    Corpechot, C.
    Chazouilleres, O.
    Rousseau, A.
    Le Gruyer, A.
    Habersetzer, F.
    Mathurin, P.
    Goria, O.
    Potier, P.
    Minello, A.
    Silvain, C.
    Abergel, A.
    Debette-Gratien, M.
    Larrey, D.
    Roux, O.
    Bronowicki, J. -P.
    Boursier, J.
    de Ledinghen, V.
    Heurgue-Berlot, A.
    Nguyen-Khac, E.
    Zoulim, F.
    Ollivier-Hourmand, I.
    Zarski, J. -P.
    Nkontchou, G.
    Lemoinne, S.
    Humbert, L.
    Rainteau, D.
    Lefevre, G.
    de Chaisemartin, L.
    Chollet-Martin, S.
    Gaouar, F.
    Admane, F. -H.
    Simon, T.
    Poupon, R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (23) : 2171 - 2181
  • [5] The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis
    Corpechot, C
    Carrat, F
    Bahr, A
    Chrétien, Y
    Poupon, RE
    Poupon, R
    [J]. GASTROENTEROLOGY, 2005, 128 (02) : 297 - 303
  • [6] Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis
    Corpechot, Christophe
    Abenavoli, Ludovico
    Rabahi, Nabila
    Chretien, Yves
    Andreani, Tony
    Johanet, Catherine
    Chazouilleres, Olivier
    Poupon, Raoul
    [J]. HEPATOLOGY, 2008, 48 (03) : 871 - 877
  • [7] Early primary biliary cirrhosis: Biochemical response to treatment and prediction of long-term outcome
    Corpechot, Christophe
    Chazouilleres, Olivier
    Poupon, Raoul
    [J]. JOURNAL OF HEPATOLOGY, 2011, 55 (06) : 1361 - 1367
  • [8] Identification of clinical risk factors for histological progression of primary biliary cholangitis
    Fujinaga, Yukihisa
    Namisaki, Tadashi
    Moriya, Kei
    Kitade, Mitsuteru
    Kawaratani, Hideto
    Shimozato, Naotaka
    Kaji, Kosuke
    Takaya, Hiroaki
    Sawada, Yasuhiko
    Seki, Kenichiro
    Akahane, Takemi
    Okura, Yasushi
    Sato, Shinya
    Saikawa, Soichiro
    Nakanishi, Keisuke
    Kubo, Takuya
    Furukawa, Masanori
    Kitagawa, Koh
    Ozutsumi, Takahiro
    Tsuji, Yuki
    Kaya, Daisuke
    Mashitani, Tsuyoshi
    Ishida, Koji
    Ogawa, Hiroyuki
    Takagi, Hirotetsu
    Noguchi, Ryuichi
    Mitoro, Akira
    Yamao, Junichi
    Yoshiji, Hitoshi
    [J]. HEPATOLOGY RESEARCH, 2019, 49 (09) : 1015 - 1025
  • [9] Changes in serum levels of leucine-rich α2-glycoprotein predict prognosis in primary biliary cholangitis
    Hayashi, Manabu
    Abe, Kazumichi
    Fujita, Masashi
    Okai, Ken
    Takahashi, Atsushi
    Ohira, Hiromasa
    [J]. HEPATOLOGY RESEARCH, 2019, 49 (04) : 385 - 393
  • [10] Hirohara Junko, 2013, Nihon Shokakibyo Gakkai Zasshi, V110, P8